Finance

Results: 3529-3540 of 44131

PCI Pharma Services announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities.

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors

Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer.

Axinn Appoints Rachael Philbin as Chief Innovation Officer

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development

PR Newswire associated0

NYSE Content Update: Former NASA Head to Ring Closing Bell for NYSE Space Summit

Microland Launches Strategic Blueprint to Help Enterprises Enable Autonomous, AI-First Operations

vVARDIS Announces Investment from Apollo —Achieves Unicorn Status

PR Newswire associated0

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach Unprecedented World Record of 5.078 Million Tokens, and Total Crypto and Total Cash Holdings of $13.3 Billion

Business Wire associated0

Peloton’s World-Class Content to Fuel Spotify’s New Fitness Category Globally

Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud

Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals

Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients